We are live on ! Find out more
MTACU

MedTech Acquisition Corporation Unit
MTACU

Delisted

MTACU was delisted on the 10th of August, 2023.

Back to rankings

4 hedge funds and large institutions have $1.35K invested in MedTech Acquisition Corporation Unit in 2023 Q2 according to their latest regulatory filings, with 1 funds opening new positions, increasing their positions, 1 reducing their positions, and 0 closing their positions.

New
Increased
Maintained
Reduced
Closed

33% more funds holding

Funds holding: 3 → 4 (+1)

33% less capital invested

Capital invested by funds: $2.02K → $1.35K (-$674)

100% less repeat investments, than reductions

Existing positions increased: 0 | Existing positions reduced: 1

Holders
4
Holders Change
+1
Holders Change %
+33.33%
% of All Funds
0.06%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
–
Reduced
1
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
CS
Clear Street
New York
+$10

Top Sellers

Rank Fund Capital Flow
1
TRCT
Tower Research Capital (TRC)
New York
-$894
Name Holding Trade Value Shares
Change 		Change in
Stake
TRCT
1
Tower Research Capital (TRC)
New York
$1.32K -$894 -87 -40%
DM
2
Deerfield Management
New York
$10 – – –
Wells Fargo
3
Wells Fargo
California
$10 – – –
CS
4
Clear Street
New York
$9 +$10 +1 New

MTACU Hedge Fund Activity: Q2 2023 in Review

4 of the 6,369 institutional investors tracked by Wall St. Rank reported a position in MedTech Acquisition Corporation Unit (MTACU) for Q2 2023, worth a combined $1.35K — down 33% from $2.02K a quarter earlier.

Buyers outnumbered sellers: 1 fund opened new MTACU positions and 0 closed out — a net gain of 1 holder — while 0 added to existing stakes and 1 trimmed.

The largest buyer was Clear Street, opening a new position worth an estimated $10. The largest seller was Tower Research Capital (TRC), cutting an estimated $894.

  • 4 institutional investors held MedTech Acquisition Corporation Unit (MTACU) as of Q2 2023, up from 3 in Q1 2023.
  • Funds reported $1.35K of MedTech Acquisition Corporation Unit stock for Q2 2023, down 33% quarter-over-quarter.
  • 1 fund opened new MedTech Acquisition Corporation Unit positions in Q2 2023 and 0 closed out, a net change of +1 holder.
  • The largest MedTech Acquisition Corporation Unit buyer in Q2 2023 was Clear Street, an estimated $10 added.
  • The largest MedTech Acquisition Corporation Unit seller in Q2 2023 was Tower Research Capital (TRC), an estimated $894 sold.

Based on aggregated 13F filings for Q2 2023.